トルコでの幹細胞療法—3つのパーソナライズクリニックマッチングを取得

Stem cell therapy is not a cure for cerebral palsy but serves as an intervention to improve motor function and quality of life. Research indicates it works by reducing neuroinflammation and supporting brain tissue repair. Treatments in Turkey typically utilize mesenchymal stem cells produced in GMP-certified laboratories.

• Incremental gains: Focused on improving spasticity, mobility, and cognitive abilities rather than full reversal.
• Treatment mechanism: Mesenchymal stem cells (MSCs) modulate the immune system and promote neuroplasticity.
• Combined protocols: Maximum efficacy requires integration with intensive physical and occupational rehabilitation programs.
• Age factor: Children under 5 often demonstrate more significant functional improvements after repeated infusions.

Bookimed Expert Insight: While many foundations offer single injections, Turkey’s leading specialist, Professor Erdal Karaöz at Liv Hospital Ulus, utilizes a multi-dose protocol. Data shows that 2 to 3 infusions spaced weeks apart significantly improve cell engraftment compared to single doses. These packages also include 16-night hotel stays, ensuring patients remain under medical observation during the critical early recovery window.

Patient Consensus: Families often report slight improvements in gait and muscle tone after two infusions. However, they emphasize that these gains require continuous, aggressive physiotherapy to prevent returning to baseline levels.

Turkish clinics primarily utilize mesenchymal stem cells for cerebral palsy, with allogeneic umbilical cord matrix-derived cells being the most frequent choice. These treatments, often performed at JCI-accredited centers like Liv Hospital Ulus, also include bone marrow-derived and adipose-derived mesenchymal stem cells to stimulate neural repair.

• Umbilical cord matrix: These allogeneic mesenchymal cells offer high potency and low immune rejection risks.
• Bone marrow-derived: Autologous cells extracted from the patient provide a mix of hematopoietic and mesenchymal types.
• Adipose-derived cells: Harvested from the patient's fat tissue, these autologous cells eliminate rejection concerns entirely.
• GMP-certified production: Facilities like Liv Hospital Ulus use Turkey's first hospital-based Good Manufacturing Practice laboratory.

Bookimed Expert Insight: While many clinics offer a standard 2-dose protocol, the most comprehensive results typically come from 3-dose packages that include 16-day hotel stays. This extended window allows for professional follow-up and vitamin infusions that help the body process the high cellular load. Professor Erdal Karaöz at Liv Hospital Ulus pioneered this specialized GMP-standard approach in Turkey, serving patients from over 180 countries.

Patient Consensus: Families often report mild motor improvements but emphasize that success depends on combining these 6-infusion cycles with intensive, long-term physical therapy. Parents suggest requesting exact COA reports to verify cell counts and lab certifications before starting the $21,000 to $22,000 treatment series.

Stem cell therapy for cerebral palsy in Turkey shows success rates between 69% and 95% for measurable clinical improvements. While not a cure, patients typically experience 20–30% better motor function, reduced spasticity, and enhanced cognitive alertness within 3 to 6 months post-treatment.

• Treatment protocols: Clinics utilize 2-dose or 3-dose mesenchymal stem cell (MSC) applications.
• Cell quality: Facilities use Good Manufacturing Practice (GMP) produced umbilical cord-derived cells.
• Medical oversight: Procedures follow Turkish Ministry of Health protocols in JCI-accredited hospitals.
• Typical stay: Protocols involve 2 days hospitalization with up to 16 days recovery.

Bookimed Expert Insight: The most effective results come from programs matching cells with intensive rehabilitation. Dr. Erdal Karaöz at Liv Hospital Ulus pioneered Turkey’s first GMP-standard center specifically for these cases. Data shows that 16-day stays are standard for premium packages. This provides the necessary window for initial physical therapy that triggers neuroplasticity.

Patient Consensus: Parents report that while dramatic cures are rare, modest gains in sitting and hand function are common. Success often depends on continuing intensive physiotherapy for at least 3 to 6 months after returning home.